Safety and Tolerability of HSC835 in Patients With Hematological Malignancies | Aplastic Anemia and MDS International Foundation

Clinical Trial: NCT01474681

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies
For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov:
Purpose: 

This study is designed to evaluate the safety and tolerability of using HSC835 in patients with hematological malignancies

Status: 
Recruiting
Study Date: 
Sun, 01/01/2012 to Tue, 08/01/2017
Bone Marrow Disease(s): 
myelodysplastic syndromes (MDS)
Intervention: 
Biological: HSC835